08.15.16
Pharmaceutical outsourcing services provider PCI Pharma Services has appointed Jim Neville as operations director at its Tredegar, UK site, to lead the continuing growth of its manufacturing business.
As part of the established operations team, Jim joins PCI Pharma Services with responsibility for all of the manufacturing and engineering activities at the Tredegar, UK site. With over 30 years of experience in the pharmaceutical industry, he has held several senior roles in other major pharmaceutical companies, most recently as site leader at Pfizer’s biotech organization and previously at Wyeth Europa on AVP technical operations with the responsibility for new product introduction, technical operations, contract manufacturing and artwork and labelling.
“We are delighted to welcome Jim Neville to the PCI Pharma Services team,” said Norman Barras, managing director of the Tredegar, UK site. “He brings with him robust experience that will be a key asset to our teams and clients during an exciting time of expansion, as we look to demonstrate continued investment at the Tredegar facility. We are looking forward to working with Jim as the site continues to evolve and grow.”
In July 2015 PCI announced a facilities expansion of its manufacturing center of excellence in Tredegar, UK. The announcement follows other recent capital investments expanding the capabilities and manufacturing capacity of the specialized site.
Visit PCI at Table 90
As part of the established operations team, Jim joins PCI Pharma Services with responsibility for all of the manufacturing and engineering activities at the Tredegar, UK site. With over 30 years of experience in the pharmaceutical industry, he has held several senior roles in other major pharmaceutical companies, most recently as site leader at Pfizer’s biotech organization and previously at Wyeth Europa on AVP technical operations with the responsibility for new product introduction, technical operations, contract manufacturing and artwork and labelling.
“We are delighted to welcome Jim Neville to the PCI Pharma Services team,” said Norman Barras, managing director of the Tredegar, UK site. “He brings with him robust experience that will be a key asset to our teams and clients during an exciting time of expansion, as we look to demonstrate continued investment at the Tredegar facility. We are looking forward to working with Jim as the site continues to evolve and grow.”
In July 2015 PCI announced a facilities expansion of its manufacturing center of excellence in Tredegar, UK. The announcement follows other recent capital investments expanding the capabilities and manufacturing capacity of the specialized site.
Visit PCI at Table 90